Higher serum ACE2 activity - implicated in the pathomechanism of various cardiovascular diseases and a risk for COVID-19 mortality - was also determined in the critically ill vs severe COVID-19 which was identical with our recent findings [19]. This evidence concerns the gene ACE2 and cardiovascular disorder.